Gelonghui, May 7, 丨 Neptune Interlon (08329.HK) announced that the company and Neptune Biotech (the company's controlling shareholder and related party) entered into a 2024 framework agreement on May 7, 2024. Based on this, the Group will purchase medical devices from Haiwang Group to be sold on behalf of China.
海王英特龙(08329.HK)将向海王集团采购医疗器械
Neptune Interlon (08329.HK) will purchase medical devices from the Neptune Group
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated